STS inhibitors are also reported to decrease the oestrogenic growth of hormone-dependent tissues, including endometrial cancer tissues (Foster et al. 2008) and proliferation of human endometrial xenografts (Colette et al. 2011). The gene discussed is STS; the disease is endometrial cancer.